Table 1 Characteristics of patients and healthy controls.

From: Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer

 

Patients with colorectal neoplasiaa (n = 92)

Healthy controls (n = 156)

Age (years), median (range)

60(32–85)

52(22–76)

Gender, male (%)

62(67.4%)

76(48.7%)

BMI(kg/m2), median (range)

23.56 (18.3–33.4)

23.0(16.9–34.6)

Advanced adenoma

36

—

CRCb

56

—

  TMN stagec

      0

24

 

      I

8

 

      II (IIA/IIB/IIC)

7

 

      III (IIIA/IIIB/IIIC)

13

 

      IV(IVA/IVB)

4

 

Serum tumor marker (>cut off valued/totale)

      CEA

2/32

1/156

      CA 19-9

2/32

1/156

  1. aColorectal neoplasia, including colorectal cancer and advanced adenoma.
  2. bCRC, colorectal cancer.
  3. cTNM stage, classified according to the American Joint Committee on Cancer (AJCC) 7th edition.
  4. dCut off value of CEA, 5 ng/ml; Cut off value of CA19-9, 37 U/ml.
  5. eTotal number of patients with stage I to 4 CRC (n = 32 patients).
Back to article page